Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT07511621

A Multi-Level Strategy for De-implementing Mammography Overuse Among Older Women

Led by Columbia University · Updated on 2026-04-06

500

Participants Needed

1

Research Sites

103 weeks

Total Duration

On this page

Sponsors

C

Columbia University

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This project aims to advance methodological and theoretical approaches for developing, selecting, refining, and piloting a multilevel de-implementation strategy to reduce the overuse of screening mammography in women aged ≥75 years. Informed by an innovative participatory, stakeholder-driven innovation tournament and a discrete choice experiment, the research team identified, prioritized, and tailored a multilevel de-implementation strategy. The research team will conduct a cluster randomized controlled trial (at the provider level) to test the impact of the provider- and patient-level components of the multilevel strategy on screening mammography use, and secondarily, on provider referrals/orders for screening mammography. The organizational level components of the multilevel strategy will be implemented among all participants, not via random assignment.

CONDITIONS

Official Title

A Multi-Level Strategy for De-implementing Mammography Overuse Among Older Women

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 75 years or older at the time of their scheduled primary care visit
  • English- or Spanish-speaking based on preferred language in electronic health record
  • Women with a primary care visit scheduled within the next 2 to 4 weeks
  • Women who have not had a screening mammogram in the past 6 months but had one 7 to 18 months prior
  • Primary care clinicians at the 2 intervention clinics serving adult patients including those 75 years and older
Not Eligible

You will not qualify if you...

  • Women with a history of atypical ductal hyperplasia or breast cancer (non-invasive or invasive)
  • Women with dementia
  • ICD codes used for exclusion include F01-F03, Z85.3, G30-G31, N60, C50, or D05
  • Specialists, primary care clinicians for patients under 18 years old, non-clinicians, and physician assistants

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Columbia University Irving Medical Center

New York, New York, United States, 10032

Actively Recruiting

Loading map...

Research Team

P

Parisa Tehranifar, DrPH

CONTACT

A

Anita G Karr, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here